Australian shares are entering the weekend on a steady note, with investors showing patience amid ongoing geopolitical discussions and national energy security measures. In this context, penny stocks—though often considered a term from past trading days—still represent viable opportunities for growth. These smaller or newer companies can offer significant potential when backed by strong financials, and this article explores three such promising stocks on the ASX that may present hidden value for investors.

Top 10 Penny Stocks In Australia

Name Share Price Market Cap Financial Health Rating West African Resources (ASX:WAF) A$3.35 A$3.83B ★★★★★★ Fenix Resources (ASX:FEX) A$0.34 A$260.09M ★★★★☆☆ LaserBond (ASX:LBL) A$0.565 A$66.78M ★★★★★★ Regal Funds Management (ASX:RPL) A$2.58 A$948.77M ★★★★★★ Praemium (ASX:PPS) A$0.695 A$338.79M ★★★★★★ Ora Banda Mining (ASX:OBM) A$1.34 A$2.58B ★★★★★★ EDU Holdings (ASX:EDU) A$0.87 A$108.7M ★★★★★★ Integrated Research (ASX:IRI) A$0.30 A$54.18M ★★★★★★ CTI Logistics (ASX:CLX) A$1.875 A$147.18M ★★★★☆☆ Cogstate (ASX:CGS) A$2.30 A$392.92M ★★★★★★

Click here to see the full list of 391 stocks from our ASX Penny Stocks screener.

Let's review some notable picks from our screened stocks.

Arovella Therapeutics

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Arovella Therapeutics Limited is a biotechnology company focused on developing cancer therapies in Australia and internationally, with a market cap of A$112.27 million.

Operations: The company's revenue is derived from its Pharmaceutical Development segment, which generated A$3.21 million.

Market Cap: A$112.27M

Arovella Therapeutics, with a market cap of A$112.27 million, remains pre-revenue and unprofitable as it focuses on developing cancer therapies. Recent earnings reported a net loss of A$1.88 million for the half-year ending December 2025, with revenue slightly declining to A$3.62 million from the previous year. The company's financial health is supported by a solid cash runway exceeding two years and no debt obligations, though management's average tenure suggests inexperience. Recent board changes and its removal from the S&P/ASX Emerging Companies Index highlight potential strategic shifts amid ongoing challenges in achieving profitability.

Click here to discover the nuances of Arovella Therapeutics with our detailed analytical financial health report. Explore historical data to track Arovella Therapeutics' performance over time in our past results report.ASX:ALA Financial Position Analysis as at Apr 2026

Civmec

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Civmec Limited is an investment holding company that offers construction and engineering services across the energy, resources, infrastructure, marine, and defense sectors in Australia, with a market cap of A$751.70 million.

Story Continues

Operations: The company's revenue is derived from three main segments: Resources (A$456.95 million), Infrastructure, Marine & Defence (A$134.51 million), and Energy (A$96.71 million).

Market Cap: A$751.7M

Civmec Limited, with a market cap of A$751.70 million, presents a mixed picture for investors in the penny stock space. The company's recent earnings report shows a decline in sales to A$380.44 million and net income to A$21.45 million for the half-year ending December 2025, compared to the previous year. Despite this, Civmec maintains strong financial health with cash exceeding total debt and short-term assets covering both short- and long-term liabilities comfortably. While its management team's tenure is relatively short at 1.6 years, the board's experience averages over 14 years, providing stability amid leadership transitions.

Get an in-depth perspective on Civmec's performance by reading our balance sheet health report here. Evaluate Civmec's prospects by accessing our earnings growth report.ASX:CVL Debt to Equity History and Analysis as at Apr 2026

Smart Parking

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Smart Parking Limited designs, develops, and manages parking management solutions across New Zealand, Australia, Denmark, Germany, and the United Kingdom with a market cap of A$456.85 million.

Operations: The company's revenue is primarily derived from its Parking Management operations in the United Kingdom (A$68.79 million), New Zealand (A$8.19 million), Germany (A$4.61 million), and Denmark (A$1.14 million), supplemented by its Technology Division, which contributes A$5.78 million.

Market Cap: A$456.85M

Smart Parking Limited, with a market cap of A$456.85 million, demonstrates potential within the penny stock segment despite some challenges. The company has achieved profitability over the past five years with earnings growth averaging 23.1% annually, although recent profit margins have decreased to 5.4% from 8.8%. Its financial position is robust, being debt-free and having short-term assets that exceed liabilities. Recent earnings for H1 2026 show sales of A$62.75 million and net income of A$4.28 million, indicating revenue growth but slightly lower basic earnings per share compared to last year. Analysts anticipate a substantial price increase potential for its stock.

Dive into the specifics of Smart Parking here with our thorough balance sheet health report. Learn about Smart Parking's future growth trajectory here.ASX:SPZ Financial Position Analysis as at Apr 2026

Where To Now?

Click this link to deep-dive into the 391 companies within our  ASX Penny Stocks screener. Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include ASX:ALA ASX:CVL and ASX:SPZ.

This article was originally published by Simply Wall St.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

View Comments